Novartis Ag (NVS) Other Non-Current Liabilities (2009 - 2026)

Novartis Ag (NVS) has 15 years of Other Non-Current Liabilities data on file, last reported at -$100.0 million in Q1 2026.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to -$100.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$100.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.1 billion, up 1.42% from the prior year.
• Other Non-Current Liabilities fell to -$100.0 million in Q1 2026 per NVS's latest filing, from $4.1 billion in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $5.4 billion in Q2 2022, with the low at -$100.0 million in Q1 2026.
• Average Other Non-Current Liabilities over 5 years is $3.2 billion, with a median of $4.1 billion recorded in 2025.
• Year-over-year, Other Non-Current Liabilities declined 14.93% in 2022 and surged 406.84% in 2024.
• Novartis Ag's Other Non-Current Liabilities stood at $874.0 million in 2022, then retreated by 8.01% to $804.0 million in 2023, then surged by 406.84% to $4.1 billion in 2024, then grew by 1.42% to $4.1 billion in 2025, then slumped by 102.42% to -$100.0 million in 2026.
• Business Quant data shows NVS's Other Non-Current Liabilities at -$100.0 million in Q1 2026, $4.1 billion in Q4 2025, and $4.2 billion in Q2 2025.